from the Israelis… double blind study favorable. Meanwhile, the pharma manufacturer rails against it’s usage & calls it ‘dangerous’.
from the Israelis… double blind study favorable. Meanwhile, the pharma manufacturer rails against it’s usage & calls it ‘dangerous’.
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.